This presentation will give an update about easing the administrative burden on the lab to assess compliance with CLSI/FDA breakpoints. Topics addressed included FDA 510(k) approvals, the VITEK® V9.04 ...
Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of antimicrobial resistance in the environment. How can global standardization fix this problem? Study: ...
WAYNE, Pa.--(BUSINESS WIRE)--The Clinical and Laboratory Standards Institute announces the publication of its annually updated antimicrobial susceptibility testing (AST) supplement M100—Performance ...
Zaynich (zidebactam/cefepime- WCK 5222) has been granted a susceptibility breakpoint of 64 mg/L for around 10 gram negative pathogens showing high resistance rates by the Clinical and Laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results